Publications by authors named "G Fraboulet"

Claim this Profile
P
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff, Olivier Bylicki, Catherine Dubos-Arvis, Gislaine Fraboulet

Cancer Manag Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study).
Romain Corre, Radj Gervais, Florian Guisier, Louis Tassy, Florent Vinas, Gislaine Fraboulet

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
Didier Debieuvre, Gislaine Fraboulet, Bernard Duvert, Jacques Piquet, Eric Goarant

Bull Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial.
Gaël Deplanque, Radj Gervais, Alain Vergnenegre, Lionel Falchero, Pierre-Jean Souquet, Ghislaine Fraboulet

J Am Acad Dermatol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).
C Raynaud, L Greillier, J Mazieres, I Monnet, B Mastroianni, G Fraboulet

BMC Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis